Clinical trial
A Prospective Randomized Study to Compare the Efficacy of Radiofrequency Ablation and Hepatic Resection as a Primary Treatment for Single Small Hepatocellular Carcinoma
NCT02482909 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized Study to Compare the Efficacy of Radiofrequency Ablation and Hepatic Resection as a Primary Treatment for Single Small Hepatocellular Carcinoma
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2005
- Completion date
- July 31, 2013
- Enrollment
- 68 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.